Christian Waage — SEC insider filings
SEC reporting owner CIK 1553179. 29 insider filings on record with FilingPulse; latest filed 2026-08-26.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2020-10-14 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 27,934 shares, $95,957 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 23,842 shares, $171,492 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 56.
- Largest priced transaction: sale of 10,722 shares @ $8.91 ($95,587) in Gossamer Bio, Inc., filed 2022-03-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | EVP, Tech Ops and Admin | 18 | 3 legs · 27,934 sh · $95,957 | 3 legs · 22,642 sh · $155,067 | 42 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 11 | — | 4 legs · 1,200 sh · $16,425 | 14 |
Insider filings — Christian Waage
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 2,900,026 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Gossamer Bio, Inc. (GOSS) | Disposition to issuer (D): 506,250 (derivative) · Disposition to issuer (D): 440,000 (derivative) · Disposition to issuer (D): 375,000 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 157,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +14 more | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-01-05 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 84,500 @ $0 · Grant/award (A): 506,250 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-03-06 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2024-03-28 | 4 | Gossamer Bio, Inc. (GOSS) | Sale (S): 6,430 @ $1.16 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-07-26 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 13,504 @ $1.82 · Grant/award (A): 3,376 (derivative) @ $0.12 | EDGAR |
| 2023-05-09 | 4 | Gossamer Bio, Inc. (GOSS) | Disposition to issuer (D): 105,000 (derivative) · Disposition to issuer (D): 71,500 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Grant/award (A): 70,000 (derivative) · Grant/award (A): 47,667 (derivative) · +2 more | EDGAR |
| 2023-03-22 | 4 | Gossamer Bio, Inc. (GOSS) | Purchase (P): 18,500 @ $1.20 · Grant/award (A): 157,500 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 38,580 @ $0 · Grant/award (A): 77,160 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 157,500 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | Gossamer Bio, Inc. (GOSS) | Purchase (P): 6,934 @ $7.21 | EDGAR |
| 2022-03-24 | 4 | Gossamer Bio, Inc. (GOSS) | Sale (S): 10,722 @ $8.91 | EDGAR |
| 2022-01-10 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale (S): 300 @ $9.73 · Grant/award (A): 10,452 @ $0 · Grant/award (A): 20,903 (derivative) @ $0 | EDGAR |
| 2021-09-23 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale (S): 300 @ $12.31 | EDGAR |
| 2021-06-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale (S): 300 @ $15.20 | EDGAR |
| 2021-04-16 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale (S): 300 @ $17.51 | EDGAR |
| 2021-03-25 | 4 | Gossamer Bio, Inc. (GOSS) | Sale (S): 5,490 @ $9.48 | EDGAR |
| 2021-03-01 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2020-12-23 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 3,000 @ $0 · Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2020-10-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 437 (derivative) @ $0 | EDGAR |
| 2020-10-14 | 4 | Gossamer Bio, Inc. (GOSS) | Purchase (P): 2,500 @ $9.53 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553179 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs